Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data

• Príomhchruthaitheoirí: Jingsong He (Údar), Donghua He (Údar), Xiaoyan Han (Údar), Gaofeng Zheng (Údar), Guoqing Wei (Údar), Yi Zhao (Údar), Yang Yang (Údar), Wenjun Wu (Údar), Jiaping Fu (Údar), Lihong Shou (Údar), Hongwei Kong (Údar), He Huang (Údar), Zhen Cai (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: Improve the treatment quality might affect patients' efficacy and survival.Methods: Five hundred thirty multiple myeloma patients treated in four hematological centers in China from February 2006 to August 2018 were enrolled. General characteristics, treatment regimens and cycles, e...